Skip to main content
. 2018 Jul 9;7:81. doi: 10.1186/s13756-018-0366-5

Table 2.

Indication and specification for contact precautions (CP) and isolationa

MRSA     GRE       E. coli ESBL     Non-E. coli ESBL
EU Non EU p-valueb EU Non EU p-valueb EU Non EU p-valueb EU Non EU p-valueb
No CP 12.7 24.5 0.165 30.0 32.7 0.396 32.7 34.7 0.636 23.3 34.7 0.044
CP only if infected 16.7 10.2 54.7 44.9 14.7 10.2 17.3 6.1
CP if colonised and/or infected 68.0 65.3 15.3 22.4 44.7 40.8 50.7 40.8
Unknown 42.7 0 0 0 5.3 10.2 6.0 14.3
ESBL not determined n.a. n.a. n.a. n.a. 2.7 4.1 2.7 33.3
Total no. responses (%) 150 (75.4) 49 (24.6) 131 (74.9) 44 (24.1) 150 (75.4) 47 (24.6) 150 (75.4) 49 (24.6)
Gowns and gloves whenever entering the room 57.3 62.9 0.398 59.0 56.7 0.623 44.9 59.1 0.234 47.3 71.4 0.046
Gowns and gloves if direct contact is anticipated 37.9 37.1 37.1 43.3 55.1 40.9 52.7 28.6
Other procedures (e.g. standard precautions only) 4.8 0.0 3.8 0.0 0 0 0 0
Total no. responses (%) 124 (78.0) 35 (22.0) 105 (77.8) 30 (22.2) 89 (80.2) 22 (19.8) 93 (81.6) 21 (18.4)
Single room 62.5 63.8 59.4 56.3 0.703 31.4 31.3 0.960 36.4 27.1 0.494
Cohorting 17.4 10.6 16.1 16.7 19.3 18. 20.7 18.8
Spatial separationc 10.4 6.4 0.235 9.8 6.3 13.6 16.7 13.6 20.8
No specific measures 9.7 19.1 14.7 20.8 35.7 33.3 29.3 33.3
Total no. responses (%) 144 (75.4) 47 (24.6) 143 (74.9) 48 (25.1) 140 (74.5) 48 (25.5) 140 (74.5) 48 (25.5)
Carbapenem resistant E. coli Carbapenem resistant non-E. coli MDR P. aeruginosa MDR A. baumannii
EU Non EU p-valueb EU Non EU p-valueb EU Non EU p-valueb EU Non EU p-valueb
No CP 11.3 16.3 0.745 8.2 18.4 0.246 13.3 20.4 0.597 9.3 20.4 0.171
CP only if infected 14.0 10.2 13.6 10.2 17.3 14.3 17.3 20.4
CP if colonised and/or infected 65.3 63.3 72.1 65.3 60.0 59.2 62.7 51.0
Unknown 9.3 10.2 6.1 6.1 9.3 6.1 10.7 8.2)
Total no. responses (%) 150 (75.4) 49 (24.6) 147 (75.0) 49 (25.0) 150 (75.4) 49 (24.6) 150 (75.4) 49 (24.6)
Gowns and gloves whenever entering the room 61.3 68.8 0.440 63.5 60.6 0.763 56.3 64.7 0.389 58.7 61.3 0.797
Gowns and gloves if direct contact is anticipated 38.7 31.3 36.5 39.4 43.7 35.3 41.3 38.7
Total no. responses (%) 111 (77.6) 32 (22.4) 115 (77.7) 33 (22.3) 103 (75.2) 34 (24.8) 109 (77.9) 31 (22.1)
Single room 64.1 41.7 0.029 71.6 47.9 0.026 56.7 43.8 0.156 61.6 45.8 0.067
Cohorting 13.4) 14.6 12.1 18.8 18.7 14.6 18.1 14.6
Spatial separationc 9.9 20.8 7.1 14.6 12.7 18.8 8.7 18.8
No specific measures 12.7 22.9 9.2 18.8 11.9 22.9 11.6 20.8
Total no. responses (%) 142 (74.7) 48 (25.3) 141 (74.6) 48 (25.4) 134 (73.6) 48 (26.4) 138 (74.2) 48 (25.8)

aValues are percentages (related to the corresponding total respondents) unless indicated otherwise

bA two-sided p-value of < 0.05 was considered statistically significant

cShared room with MDRO-negative patients but with optical barrier (e.g. red margin on the floor) or separated by screen/curtains